Alsike clover
Alsike clover
Description
Systematic position and nature. Alsike clover (Trifolium hybridum) belongs to the kingdom Plantae, the family Fabaceae, and the genus Trifolium. While traditionally used as forage, in modern phytopathology, it is recognized as a significant reservoir for various plant pathogens that pose a severe threat to cultivated legume crops and other agricultural species.
Diseases and susceptible crops. This plant species frequently harbors pathogens such as Sclerotinia trifoliorum (clover rot) and various anthracnose-causing fungi. Furthermore, it serves as a critical host for viruses like the clover yellow vein virus, which can easily transmit to commercial soybean, bean, and clover fields via aphid vectors, causing extensive damage.
Biology and life cycle. Alsike clover is a perennial plant with a robust root system, allowing it to persist in the field for several years. This persistence makes it an ideal medium for the overwintering of fungal mycelia and spores. The pathogen life cycle is thus synchronized with the clover’s growth, ensuring a constant supply of inoculum for the upcoming growing season.
Developmental conditions and harm. The plant thrives in cool, moist, and poorly drained soils, which are also conducive environments for many fungal pathogens. Its harm is twofold: it competes with crops for sunlight, nutrients, and water, while simultaneously acting as an active source of infection, significantly reducing yields and impacting the economic viability of the agricultural operation.
Protection and control measures. Management strategies should focus on eliminating the clover from crop rotation cycles where sensitive legumes are present. Key measures include:
- Deep plowing to eliminate root reserves.
- Application of selective systemic herbicides during the early vegetative stage.
- Maintaining strict buffer zones between wild clover patches and commercial crops.
- Regular field monitoring to detect early symptoms of infection spreading from wild host plants.
Вызывает болезни · 1
Discussion
No discussions yet — be the first.